Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Synex Medical | 2024 | Series A | $21.8M | Toronto |
| Noetik | 2024 | Grant | $1.0M | South San Francisco |
| Cellino | 2024 | Grant | $25.0M | Cambridge |
| Essor | 2024 | Debt Financing | Undisclosed | Paris |
| EGenesis | 2024 | Series D | $191.0M | Cambridge |
| Openwater | 2024 | Series Unknown | $54.0M | San Francisco |
| Mudstack | 2024 | Seed | $4.0M | Roswell |
| Earli | 2024 | Series Unknown | Undisclosed | South San Francisco |
| Ambri | 2024 | Series Unknown | $11.1M | Marlborough |
| Neon | 2024 | Series Unknown | $25.6M | Menlo Park |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 576 | Synex Medical | Series A | $21.8M | Toronto, Canada |
| 577 | Noetik | Grant | $1.0M | South San Francisco, United States |
| 578 | Cellino | Grant | $25.0M | Cambridge, United States |
| 579 | Essor | Debt Financing | Undisclosed | Paris, France |
| 580 | EGenesis | Series D | $191.0M | Cambridge, United States |
| 581 | Openwater | Series Unknown | $54.0M | San Francisco, United States |
| 582 | Mudstack | Seed | $4.0M | Roswell, United States |
| 583 | Earli | Series Unknown | Undisclosed | South San Francisco, United States |
| 584 | Ambri | Series Unknown | $11.1M | Marlborough, United States |
| 585 | Neon | Series Unknown | $25.6M | Menlo Park, United States |
Synex Medical develops non-invasive blood testing technology.
Noetik is an AI-native biotechnology company that applies machine learning to large-scale human multimodal spatial omics datasets.
Cellino is building an ultra-scalable biomanufacturing technology stack for personalized cell, tissue, and organ replacement therapies.
Essor provider of a digital consumer product platform.
EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.
Openwater is a startup developing a medical technology system focused on treating diseases at the cellular level.
Mudstack is an asset management platform for game studios and artists.
Earli develops genetic constructs for early cancer detection and targeted therapy.
Ambri is an energy storage solutions company that develops liquid metal batteries.
Neon is a software development company specializing in open-source cloud-native PostgreSQL database solutions.
Teamshares is an employee ownership platform for small business.
On a mission to build the first Clinical Digital Twin Platform and make it accessible to everyone
Upliance.ai is a D2C, smart home appliance brand at the forefront of transforming modern Indian households.
We capture the most plentiful protein on the planet, Rubisco from green leaves
Found is a fintech company that provides business banking services for self-employed people.
Honey Homes is a home maintenance firm that offers house maintenance and related services.
Nabla Bio is an autoverse platform of proprietary biologically informed machine learning that co-develops antibody drugs.
Pascal is a technological company that is developing a new class of solid refrigerants with the potential to alter HVAC sector.
Karius delivers genomic insights into infectious diseases, helping clinicians make critical, life-saving treatment decisions.
Zeck is an application that offers communication features for meetings.
YonedaLabs is an AI-based software that assists chemists in optimizing reaction parameters such as temperature, concentration, and catalyst.
Rubedo Life Sciences focuses on developing medicines that target the specific cells responsible for aging, known as pathologic cells.
vCluster helps companies build flexible infrastructure tenancy for GPU and AI infra as well as for K8s in private, public and hybrid clouds.
Collaborative Robotics is building robots that help in indoor and outdoor tasks alongside humans.
Symbolica AI operates as a research-focused company.
Khosla Ventures has invested in 783 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Khosla Ventures's top investment sectors include Biotechnology, Artificial Intelligence (AI), Software, Information Technology, Life Science. The firm invests across 56 different industry categories.
Among tracked funding rounds, EGenesis received $191.0M in a Series D round. Khosla Ventures's total known invested capital is $34.0B.
Khosla Ventures's average investment size is $55.2M across its portfolio of 783 companies.
Recent Khosla Ventures portfolio additions include Synex Medical, Noetik, Cellino, Essor, EGenesis. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors